BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7195962)

  • 1. Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model.
    Drago JR; Worgul T; Gershwin ME
    J Surg Oncol; 1981; 16(4):353-63. PubMed ID: 7195962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III.
    Drago JR
    J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
    Drago JR; Worgul T
    Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of the Nb rat in combination chemotherapeutic experiments for prostate cancer.
    Drago JR; Smith J
    In Vivo; 1991; 5(1):41-2. PubMed ID: 1932624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
    Drago JR; Worgul TJ
    Invest Urol; 1981 Nov; 19(3):191-3. PubMed ID: 7298290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nb rat prostate adenocarcinoma model: evaluation of the subrenal capsular assay system.
    Drago JR; Lombard J
    J Surg Oncol; 1985 Apr; 28(4):270-2. PubMed ID: 3884903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
    Drago JR; Goldman LB; Gershwin ME
    Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
    Drago JR; Palmer J
    J Surg Oncol; 1983 Nov; 24(3):215-7. PubMed ID: 6632910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
    Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
    Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemotherapy of prostatic adenocarcinoma.
    Torti FM; Carter SK
    Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the Nb rat model.
    Nesbitt JA; Smith J; McDowell G; Drago JR
    J Surg Oncol; 1988 Aug; 38(4):283-4. PubMed ID: 3411971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
    Block NL; Camuzzi F; Denefrio J; Troner M; Claflin A; Stover B; Politano VA
    Oncology; 1977; 34(3):110-3. PubMed ID: 917440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of the usefulness of endocrine therapy combined with chemotherapy as an initial treatment of prostatic cancer].
    Matsuoka K; Yoshitake N; Noguti M; Tanaka H; Noda S; Eto K
    Nihon Hinyokika Gakkai Zasshi; 1988 Sep; 79(9):1559-66. PubMed ID: 3244222
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotesting of prostate cancer in xenografts.
    Byard MA; Smith JJ; Drago JR
    J Surg Oncol; 1989 Jul; 41(3):198-200. PubMed ID: 2747245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for advanced gynecological carcinoma with cis-dichlorodiammineplatinum (II), adriamycin and/or cyclophosphamide after failure of initial treatment (author's transl)].
    Takizawa K; Matsuzawa M; Takahashi M; So E; Hasumi K; Sampi K
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1292-1302. PubMed ID: 7199554
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat (Pr-90) prostatic carcinoma.
    Drago JR; Goldman LB
    Cancer; 1980 Feb; 45(4):757-63. PubMed ID: 7357493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and concomitant chemoradiotherapy in the NB rat prostate adenocarcinoma model.
    Klump R; Pieters RS; Smith JJ; Badalament RA; Drago JR
    In Vivo; 1989; 3(2):109-11. PubMed ID: 2519835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.